SCHEMBL2309692

SCHEMBL2309692

OCCc1ccc2c3cccc4cccc(c5cccc1c52)c43

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 4/20 0.40
ALDH1A1 P00352 4/20 0.40
HPGD P15428 3/20 0.40
HSD17B10 Q99714 3/20 0.40
THRB P10828 1/20 0.40
ERBB2 P04626 1/20 0.37
FYN P06241 1/20 0.37
MAOA P21397 1/20 0.37
ACHE P22303 1/20 0.37
AHR P35869 1/20 0.37
KDM4E B2RXH2 3/20 0.35
POLB P06746 2/20 0.33
MTNR1A P48039 2/20 0.33
GLA P06280 1/20 0.33
CYP2D6 P10635 1/20 0.33
HTT P42858 1/20 0.33
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2310471 0.92 MEN1 (0.41) KMT2AMEN1CYP1A2ALDH1A1HPGD
SCHEMBL2307243 0.92 MEN1 (0.41) KMT2AMEN1CYP1A2ALDH1A1HPGD
SCHEMBL2310217 0.91 KMT2A (0.44) KMT2AMEN1CYP1A2ALDH1A1HPGD
SCHEMBL2307308 0.90 KMT2A (0.50) KMT2AMEN1CYP1A2ALDH1A1HPGD
SCHEMBL2308433 0.90 KMT2A (0.50) KMT2AMEN1CYP1A2ALDH1A1HPGD
SCHEMBL2313073 0.89 CYP1A2 (0.40) KMT2AMEN1CYP1A2ALDH1A1HPGD
SCHEMBL2313029 0.87 MEN1 (0.38) KMT2AMEN1CYP1A2ALDH1A1HPGD
SCHEMBL29980106 0.86 KMT2A (0.62) KMT2AMEN1CYP1A2ALDH1A1HPGD
SCHEMBL2314130 0.86 KMT2A (0.62) KMT2AMEN1CYP1A2ALDH1A1HPGD
SCHEMBL27523973 0.86 MEN1 (0.50) KMT2AMEN1CYP1A2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989517-B2 Actinic ray curable composition, actinic ray curable ink, and image formation process employing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-08-02 US disclosed
US-20070123600-A1 ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, AND IMAGE FORMATION PROCESS EMPLOYING THE SAME KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-31 US disclosed